A number of `threads' of comment about creatinine clearance ran on the ACB mailbase from April 1999. (There is a mail archive on the ACB web site, http://www.acb.org.uk.) Topics included the validity of urine measurement in patients with oliguria; the effect of meat in the diet on creatinine production; formulae for calculating creatinine clearance from plasma creatinine, age and weight without urine collection; `correction' of measured creatinine clearance for body surface area; and the role of serum cystatin C in the assessment of glomerular filtration rate (GFR).
The first question might be rephrase d to ask whether creatinine clearance is ever a valid measure of GFR. Inulin clearance is the gold standard. Clearance values for creatinine are higher than those for inulin and diverge widely. For example, under experimental rather than clinical conditions, at an inulin clearance of 50 mL/min, creatinine clearance ranged from about 50 to 140 mL/min. 1 Plasma concentrations of creatinine increase after eating a meal containing boiled meat, rising for example from about 90 µmol/L to 175 µmol/L in 3 h after a substantial goulash. 2 Increased urine excretion rate follows, so measured clearance will inevitably be distorted.
The algorithm of Cockcroft and Gault 3 for predicting creatinine clearance from plasma creatinine was intended as a bedside approximation, but even so its precision was poor. At a measured creatinine clearance of 100 mL/min, predicted values ranged from about 75 to 160 mL/min. More recently, predicted creatinine clearance has been compared directly with true GFR measured using iothalam a t e . 4 At a GFR of 100 mL/min, predictions ranged from 60 to 170 mL/min, and at 50 mL/min they ranged from 20 to 115 mL/min.
In marked c ontrast, there is close agreement between inulin clearance and GFR measurements using isotopic methods that do not require urine c o l l e c t i o n . 1, 5 Materials that are used include [ 5 1 Cr] edetate, [ 1 2 5 I] iothalamate and [ 9 9 T c m ] d i e t h y lenetriamine penta-acetic acid (DTPA). Shemesh et a l. 1 suggested that the occasional measurement of true GFR using an isotopic method would establish its relationship with plasma creatinine concentration for an individual patient, and that plasma creatinine could then be used for monitoring. Cameron and Greger 5 believe that for ordinary clinical practice, the plasma creatinine concentration measured by a rate-dependent method is adequate for assessing glomerular function when i t i s over 200 µ mol/L; below that level, an isotopic method should be used.
What is the future role of plasma cystatin C? It is likely to prove more sensitive than plasma creatinine in detecting mild impairment of glomerular function, 6 so its role might be to determine whether measurement of true GFR is indicated in patients (such as those about to undergo chemotherapy) in whom some degree of impairment might be clinically important.
Meanwhile, let us use scientific argument to persuade our clinical colleagues to abandon creatinine clearance and its prediction, to use an isotopic method when GFR measurement is really needed and to continue to monitor changing glomerular function using plasma creatinine concentration.
